Rapt Therapeutics
Oct 24, 2019
Rapt Therapeutics files IPO; Novartis stakes $80M for NASH
Rapt Therapeutics files for IPO at $75M Rapt Therapeutics, based in the US, filed to raise to $75 million in its IPO. This had come after five months when the company had retitled itself, which was earlier known as Flx Bio and after three months, it had filed its initial S-1 form with the hope to gain $86 millio...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
